Authors
Patricia Duchêne, Director Regulatory Affairs, Celgene Corporation, US; Monique Garrett, CEO, PrismWorks, LLC;
Sara Snow, Senior Associate II, Regulatory Development, Biogen Idec
This article represents views of senior US regulatory leaders on current hot topics for regulatory professionals.
- What is the biggest challenge you see facing the US regulatory affairs community in the coming year?
- Are you witnessing any new trends in the regulatory affairs arena that you think will impact approval processes in the US?
- How do you think agency/sponsor relations will change in the coming year?
- Do you have any advice for regulatory professionals who may be planning on submitting in the US?
Implementation of generic user feet act , will be the major challenge to the US FDA authority this coming year i guess.
ReplyDeleteHi
Deleteyes correct.
Check it once reference file "All in a day’s work".